Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Collins, Peter ^a   Baudo, Francesco ^b   Huth Kühne, Angela ^c   Ingerslev, Jørgen ^d   Kessler, Craig M ^e   Castellano, Maria E Mingot ^f   Shima, Midori ^g   St Louis, Jean ^h   Lévesque, Hervé ⁱ  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Hemophilia Center   (Germany)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^f Hospital Carlos Haya   (Spain)

^g NARA MEDICAL UNIVERSITY   (Japan)

^h MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

ⁱ UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954339906     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-161     Document Type: Article

References (45)

1. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. J Delgado V Jimenez-Yuste F Hernandez-Navarro A Villar, Br J Haematol 2003 121 1 21 35 10.1046/j.1365-2141.2003.04162.x 12670328
2. Acquired haemophilia. CR Hay, Baillieres Clin Haematol 1998 11 2 287 303 10.1016/S0950-3536(98)80049-8 10097808
3. Acquired Inhibitors to Factor VIII. CM Kessler E Asatiani, Textbook of Hemophilia, Lee CA, Berntorp EE, Hoots WK, Aledort LM, 2007 86 90
4. Acquired haemophilia and its management. AE Morrison CA Ludlam, Br J Haematol 1995 89 2 231 236 10.1111/j.1365-2141.1995.tb03294.x 7873371
5. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. PW Collins S Hirsch TP Baglin G Dolan J Hanley M Makris DM Keeling R Liesner SA Brown CR Hay, Blood 2007 109 5 1870 1877 10.1182/blood-2006-06- 029850 17047148
6. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. P Collins N Macartney R Davies S Lees J Giddings R Majer, Br J Haematol 2004 124 1 86 90 10.1046/j.1365-2141.2003.04731.x 14675412
7. Epidemiology and one-year outcomes in patients with acquired hemophilia in France. JY Borg H Levesque for the SACHA study group, J Thromb Haemost 2007 5 suppl 1 O-M-062
8. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. D Green K Lechner, Thromb Haemost 1981 45 3 200 203 6792737
9. Treatment of acquired hemophilia A. PW Collins, J Thromb Haemost 2007 5 5 893 900 10.1111/j.1538-7836.2007.02433.x 17461924
10. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. CR Hay S Brown PW Collins DM Keeling R Liesner, Br J Haematol 2006 133 6 591 605 10.1111/j.1365-2141.2006.06087.x 16704433
11. Acquired haemophilia in the elderly. F Baudo F de Cataldo, Blood Disorders in the Elderly Cambridge: Cambridge University Press, Balducci L, Ershler W, de Gaetano G, 2007 389 407
12. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. A Huth-Kuhne F Baudo P Collins J Ingerslev CM Kessler H Levesque ME Castellano M Shima J St-Louis, Haematologica 2009 94 4 566 575 10.3324/haematol.2008.001743 19336751
13. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. G Guyatt D Gutterman MH Baumann D Addrizzo-Harris EM Hylek B Phillips G Raskob SZ Lewis H Schunemann, Chest 2006 129 1 174 181 10.1378/chest.129.1.174 16424429 (Pubitemid 43265259)
14. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. AE Morrison CA Ludlam C Kessler, Blood 1993 81 6 1513 1520 8453098
15. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. R Lottenberg TB Kentro CS Kitchens, Arch Intern Med 1987 147 6 1077 1081 10.1001/archinte.147.6.1077 3109341
16. Guidelines on the investigation and management of the antiphospholipid syndrome. M Greaves H Cohen SJ MacHin I Mackie, Br J Haematol 2000 109 4 704 715 10.1046/j.1365-2141.2000.02069.x 10929019
17. Laboratory tests for factor VIII inhibitors, their variation, significance and interpretation. CK Kasper, Blood Coagul Fibrinolysis 1991 2 suppl 1 7 10 1773000
18. Detection of factor VIII inhibitors with the partial thromboplastin time. TS Lossing CK Kasper DI Feinstein, Blood 1977 49 5 793 797 856360
19. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. AR Giles B Verbruggen GE Rivard J Teitel I Walker, Thromb Haemost 1998 79 4 872 875 9569207
20. Acquired factor VIII inhibitors. M Franchini G Lippi, Blood 2008 112 2 250 255 10.1182/blood-2008-03-143586 18463353
21. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. CR Hay C Negrier CA Ludlam, Thromb Haemost 1997 78 6 1463 1467 9423795
22. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. MJ Sumner BD Geldziler M Pedersen S Seremetis, Haemophilia 2007 13 5 451 461 10.1111/j.1365-2516.2007.01474.x 17880429
23. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. S Sallah, Haemophilia 2004 10 2 169 173 10.1046/j.1365-2516.2003. 00856.x 14962206
24. NovoSeven Summary of Product Characteristics. Novo Nordisk Health Care AG, 2006
25. FEIBA VH Anti-inhibitor coagulant complex Vapor Heated. Baxter Corp, Summary of Product Characteristics 2005
26. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. J Astermark SM Donfield DM DiMichele A Gringeri SA Gilbert J Waters E Berntorp, Blood 2007 109 2 546 551 10.1182/blood-2006-04-017988 16990605
27. Human factor VIII for bleeding in patients with inhibitors. CK Kasper, Vox Sang 1999 77 Suppl 1 47 48 10.1159/000056716 10529688
28. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. H Zeitler G Ulrich-Merzenich L Hess E Konsek C Unkrig P Walger H Vetter HH Brackmann, Blood 2005 105 6 2287 2293 10.1182/blood-2004-05-1811 15542586
29. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. J Freedman ML Rand O Russell C Davis PL Cheatley V Blanchette MB Garvey, Transfusion 2003 43 11 1508 1513 10.1046/j.1537-2995.2003.00559.x 14617307
30. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor. M Muhm N Grois P Kier A Stumpflen P Kyrle I Pabinger P Bettelheim W Hinterberger K Lechner, Haemostasis 1990 20 1 15 20 2108912
31. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor. B de la Fuente S Panek LW Hoyer, Br J Haematol 1985 59 1 127 131 10.1111/j.1365-2141. 1985.tb02972.x 3918556
32. Desmopressin therapy in patients with acquired factor VIII inhibitors. SM Naorose-Abidi LR Bond A Chitolie DH Bevan, Lancet 1988 1 8581 366 10.1016/S0140-6736(88)91169-5 2893182
33. DDAVP in acquired hemophilia A: case report and review of the literature. R Mudad WH Kane, Am J Hematol 1993 43 4 295 299 10.1002/ajh.2830430413 8372811
34. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. D Green AW Rademaker E Briet, Thromb Haemost 1993 70 5 753 757 8128430
35. Rituximab in the treatment of acquired factor VIII inhibitors. A Wiestner HJ Cho AS Asch MA Michelis JA Zeller EI Peerschke BB Weksler GP Schechter, Blood 2002 100 9 3426 3428 10.1182/blood-2002-03-0765 12384448
36. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. R Stasi M Brunetti E Stipa S Amadori, Blood 2004 103 12 4424 4428 10.1182/blood-2003-11-4075 14996701
37. Rituximab in the treatment of adult acquired hemophilia A: a systematic review. M Franchini, Crit Rev Oncol Hematol 2007 63 1 47 52 10.1016/j. critrevonc.2006.11.004 17236786
38. Acquired factor VIII inhibitors in nonhemophilic patients. D Sohngen C Specker D Bach BM Kuntz M Burk C Aul G Kobbe A Heyll KA Hollmig W Schneider, Ann Hematol 1997 74 2 89 93 10.1007/s002770050263 9063379
39. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. EC Lian AF Larcada AY Chiu, Ann Intern Med 1989 110 10 774 778 2496636
40. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. LG Shaffer MD Phillips, Ann Intern Med 1997 127 3 206 209 9245226
41. Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone. EC Lian MJ Villar LI Noy Z Ruiz-Dayao, Am J Hematol 2002 69 4 294 295 10.1002/ajh.10070 11921026
42. Acquired hemophilia due to factor VIII inhibitors in 34 patients. P Bossi J Cabane J Ninet R Dhote T Hanslik O Chosidow C Jouan-Flahault MH Horellou F Leynadier E Liozon,, et al. Am J Med 1998 105 5 400 408 10.1016/S0002-9343(98) 00289-7 9831424 (Pubitemid 28536225)
43. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. YW Huang P Saidi C Philipp, Haemophilia 2004 10 6 713 721 10.1111/j.1365-2516.2004.01031.x 15569166
44. Rituximab in the treatment of acquired factor VIII inhibitors. AA Onitilo A Skorupa A Lal E Ronish RJ Mercier R Islam J Lazarchick, Thromb Haemost 2006 96 1 84 87 16807656
45. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. WH Geerts GF Pineo JA Heit D Bergqvist MR Lassen CW Colwell JG Ray, Chest 2004 126 3 Suppl 338S 400S 10.1378/chest.126.3-suppl.338S 15383478